Share chart Simcere Pharmaceutical Group Limited
About Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited занимается исследованием, разработкой, производством и продажей фармацевтической продукции для дистрибьюторов, аптечных сетей и других производителей фармацевтической продукции в Китае. Компания фокусируется на различных терапевтических областях, включая онкологию, центральную нервную систему, аутоиммунную, противоинфекционную, сердечно-сосудистую и другие. more details| ISIN | HK0000658531 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Див.доход ао | 3.16 |
| Дивиденд ао | 0.1757 |
| Сайт | https://www.simcere.com |
| Цена ао | 8.09 |
| Change price per day: | -0.492% (8.13) |
|---|---|
| Change price per week: | +3.59% (7.81) |
| Change price per month: | +8.59% (7.45) |
| Change price per 3 month: | +19.67% (6.76) |
| Change price per half year: | +29.44% (6.25) |
| Change price per year: | +47.36% (5.49) |
| Change price per 3 year: | -0.7362% (8.15) |
| Change price per year to date: | +17.25% (6.9) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 6619000 | 0.25 |
| Vanguard International Stock Index-Total Intl Stock Indx | 6480248 | 0.25 |
| DFA Emerging Markets Core Equity Portfolio | 3473000 | 0.13 |
| WisdomTree Tr-WisdomTree Emerging Markets Small Cap Dividend Fund | 2721000 | 0.1 |
| DFA Emerging Markets Small Cap Series | 2538000 | 0.1 |
| Avantis Emerging Markets Equity Fund | 2439000 | 0.09 |
| Avantis Emerging Markets Equity ETF | 2330000 | 0.09 |
| First Tr Exchg Tr AlphaDEX Fd-FT Emerging Markets Small Cap AlphaDex | 1966054 | 0.08 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 1871000 | 0.07 |
| Principal Global Emerging Markets Fund | 926000 | 0.04 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| WisdomTree Emerging Markets SmallCap Dividend Fund | 0.0711 | 1.35 | 5.00999 |
| Avantis Emerging Markets Equity ETF | 0.0389 | 8.77 | 3.60513 |
SPDR S&P China ETF
|
0.03379 | 17.02 | 3.40103 |
| Avantis Emerging Markets Value ETF | 0.03009 | 14.12 | 4.22231 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.01379 | 15.96 | 3.34087 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.01 | 9.39 | 3.09932 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.00572 | 13.06 | 3.62488 |
| Vanguard ESG International Stock ETF | 0 | 6.39 | 3.07501 |
| 0.03 | 10.76 | 3.67 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Jinsheng Ren | Co-Founder, Chairman & CEO | 3.13M | 1962 (63 years) |
| Mr. Yushan Wan | CFO, Joint Company Secretary & Executive Director | 7.49M | 1970 (55 years) |
| Mr. Renhong Tang Ph.D. | Executive Director | 14.56M | 1981 (44 years) |
| Mr. Quanfu Feng | Vice President of Marketing | N/A | 1965 (60 years) |
| Dr. Tamas Oravecz Ph.D. | Senior VP & Chief Scientific Officer of Simcere Zaiming | N/A | |
| Ms. Xi Wang | VP & Executive Director | N/A | 1983 (42 years) |
| Mr. Gaobo Zhou | Chief Investment Officer | N/A | 1979 (46 years) |
| Dr. Aik Han Goh | Senior VP & Chief Medical Officer | 1975 (50 years) | |
| Mr. Wang John | Senior Vice President | 1961 (64 years) | |
| Dr. Yongyu Wang | Senior VP & Chief Medical Officer of Simcere Zaiming |
Address: China, Nanjing, No. 699-18 Xuanwu Road - open in Google maps, open in Yandex maps
Website: https://www.simcere.com
Website: https://www.simcere.com
